La Jolla Pharmaceutical OverviewLa Jolla Pharmaceutical Cost of Revenue
Cost of Revenue analysis for LJPC.
Quarterly Cost of Revenue
$1.69M
↓ 21.57% YoY
As of Jun 30, 2022
Annual Cost of Revenue (TTM)
$8.86M
↓ 40.04% YoY
Trailing 12 months ending Jun 30, 2022